Point-Of-Sale Rebates In Part D Could Save Seniors $20bn, PhRMA Argues

PhRMA President Ubl discusses drug pricing advocacy priorities in Medicare Part D during media briefing.

Silhouette-Seniors-In-Pills_1200x675

Passing through negotiated rebates at the point-of-sale in Medicare Part D could save beneficiaries up to $20bn over 10 years, the Pharmaceutical Research and Manufacturers of America says.

Savings to Medicare could reach $70bn over 10 years, assuming certain behavioral changes and a market response to the redistribution...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Pricing Debate

More from Market Access